Hicks Derek - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 1, 2024, Hicks Derek's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Business Officer), and currently has 66,380 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
Hicks Derek - Insider Non-Derivative Transactions of NTLA Common Stock
Hicks Derek - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 2, 2024 | Acquisition -- (Common Stock) | 29393 | 0 | 66380 |
| Jan 4, 2024 | Sell -- (Common Stock) | 3877 | 29.46 | 36987 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 23558 | 0 | 40864 |
| Jan 5, 2023 | Sell -- (Common Stock) | 1812 | 37.21 | 17306 |